✦ LIBER ✦

A double blind trial of UK-38,485, an orally active thromboxane synthetase inhibitor, in the treatment of Raynaud’s syndrome

✍ Scribed by M. H. A. Rustin; S. M. Grimes; I. B. Kovacs; E. D. Cooke; S. A. Bowcock; S. O. Sowemimo-Coker; P. Turner; J. D. T. Kirby

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A double blind trial of UK-38,485, an or

✍ M. H. A. Rustin; S. M. Grimes; I. B. Kovacs; E. D. Cooke; S. A. Bowcock; S. O. S 📂 Article 📅 1984 🏛 Springer 🌐 English ⚖ 548 KB

Dazoxiben, a thromboxane synthetase inhi

✍ JJ Belch; J Cormie; P Newman; M McLaren; J Barbenel; H Capell; P Leiberman; CD F 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 507 KB

Oral pentasa in the treatment of active

✍ HANAUER, S 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 132 KB

A double-blind clinical trial to compare

✍ Sandra A Le Vasseur; Robert D Helme 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 456 KB